- Home
- APRE vs TWAV Comparison
APRE vs TWAV Comparison
Compare APRE & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.72
N/A
Current Price
$1.21
Company Overview
Basic Information| Metric | APRE | TWAV |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0M | 7.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | APRE | TWAV |
|---|---|---|
| Price | $0.72 | $1.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 231.3K | 116.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.58 |
| 52 Week High | $2.65 | $2.41 |
Technical Indicators
Market Signals| Indicator | APRE | TWAV |
|---|---|---|
| Relative Strength Index (RSI) | 41.59 | 57.11 |
| Support Level | $0.55 | $0.96 |
| Resistance Level | $0.98 | $2.30 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 2.44 | 74.17 |
Price Performance
Historical Comparison APRE
TWAV
About APRE Aprea Therapeutics Inc.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.